Market revenue in 2023 | USD 268.6 million |
Market revenue in 2030 | USD 445.2 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Volumetric infusion pumps |
Fastest growing segment | Insulin Infusion Pumps |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Volumetric Infusion Pumps, Syringe Infusion Pumps, Insulin Infusion Pumps, Enteral Infusion Pumps, Ambulatory Infusion Pumps, Patient-Controlled Analgesia Infusion Pumps, Implantable Infusion Pumps, Other Infusion Pumps |
Key market players worldwide | Baxter International Inc, B. Braun, Medtronic PLC, Micrel Medical Devices, Boston Scientific Corp, Fresenius SE & Co KGaA, Roche Holding AG, Tandem Diabetes Care Inc, Terumo Corp, Moog Inc A, IRadimed Corp, CareFusion, Smiths Group PLC, Mindray Medical International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intravenous infusion pumps market will help companies and investors design strategic landscapes.
Volumetric infusion pumps was the largest segment with a revenue share of 16.83% in 2023. Horizon Databook has segmented the Canada intravenous infusion pumps market based on volumetric infusion pumps, syringe infusion pumps, insulin infusion pumps, enteral infusion pumps, ambulatory infusion pumps, patient-controlled analgesia infusion pumps, implantable infusion pumps, other infusion pumps covering the revenue growth of each sub-segment from 2018 to 2030.
According to an article by Global News, only 11% of women and 13% of men in Canada are completely satisfied with their appearance. According to the Canadian Institute of Health Information, the total healthcare expenditure in Canada was about USD 264 billion in 2019, which is USD 7,068 per person, representing 11.6% of the country’s GDP.
High healthcare expenditure and presence of advanced healthcare facilities are some key factors fueling the Intravenous Infusion Pump Market in Canada. The Canadian Association of Medical Spas and Aesthetic Surgeons (CAMACS) recognizes the need for proper guidelines due to the increasing number of cosmetic procedures.
It also provides a list of approved procedures in Canada by certifying and accrediting them. The organization has also realized the importance and benefits of noninvasive procedures and is creating awareness for the same.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada intravenous infusion pumps market , including forecasts for subscribers. This country databook contains high-level insights into Canada intravenous infusion pumps market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account